![[Analysis 1.1]](/images/14651858/forrest_default.gif) | Analysis 1.1. Comparison 1 Exclusive versus mixed breastfeeding 4-6 months, developing countries, controlled trials, Outcome 1 Monthly weight gain from 4-6 months (g/mo). |
| Analysis 1.2. Comparison 1 Exclusive versus mixed breastfeeding 4-6 months, developing countries, controlled trials, Outcome 2 Monthly weight gain from 6-12 months (g/mo). |
| Analysis 1.3. Comparison 1 Exclusive versus mixed breastfeeding 4-6 months, developing countries, controlled trials, Outcome 3 Monthly length gain 4-6 months (cm/mo). |
| Analysis 1.4. Comparison 1 Exclusive versus mixed breastfeeding 4-6 months, developing countries, controlled trials, Outcome 4 Monthly length gain 6-12 months (cm/mo). |
| Analysis 1.5. Comparison 1 Exclusive versus mixed breastfeeding 4-6 months, developing countries, controlled trials, Outcome 5 Weight-for-age z-score at 6 months. |
| Analysis 1.6. Comparison 1 Exclusive versus mixed breastfeeding 4-6 months, developing countries, controlled trials, Outcome 6 Length-for-age z-score at 6 months. |
| Analysis 1.7. Comparison 1 Exclusive versus mixed breastfeeding 4-6 months, developing countries, controlled trials, Outcome 7 Weight-for-length z-score at 6 months. |
| Analysis 1.8. Comparison 1 Exclusive versus mixed breastfeeding 4-6 months, developing countries, controlled trials, Outcome 8 Weight-for-age z-score < -2 at 6 months. |
| Analysis 1.9. Comparison 1 Exclusive versus mixed breastfeeding 4-6 months, developing countries, controlled trials, Outcome 9 Length-for-age z-score < -2 at 6 months. |
| Analysis 1.10. Comparison 1 Exclusive versus mixed breastfeeding 4-6 months, developing countries, controlled trials, Outcome 10 Weight-for-length z-score < -2 at 6 months. |
| Analysis 1.11. Comparison 1 Exclusive versus mixed breastfeeding 4-6 months, developing countries, controlled trials, Outcome 11 Receipt of Fe supplements 6-9 months. |
| Analysis 1.12. Comparison 1 Exclusive versus mixed breastfeeding 4-6 months, developing countries, controlled trials, Outcome 12 Hemoglobin concentration (g/L) at 6 months. |
| Analysis 1.13. Comparison 1 Exclusive versus mixed breastfeeding 4-6 months, developing countries, controlled trials, Outcome 13 Hemoglobin concentration < 110 g/L at 6 months. |
| Analysis 1.14. Comparison 1 Exclusive versus mixed breastfeeding 4-6 months, developing countries, controlled trials, Outcome 14 Hemoglobin concentration < 103 g/L at 6 months. |
| Analysis 1.15. Comparison 1 Exclusive versus mixed breastfeeding 4-6 months, developing countries, controlled trials, Outcome 15 Hematocrit (%) at 6 months. |
| Analysis 1.16. Comparison 1 Exclusive versus mixed breastfeeding 4-6 months, developing countries, controlled trials, Outcome 16 Hematocrit < 33% at 6 months. |
| Analysis 1.17. Comparison 1 Exclusive versus mixed breastfeeding 4-6 months, developing countries, controlled trials, Outcome 17 Plasma ferritin concentration (mcg/L) at 6 months. |
| Analysis 1.18. Comparison 1 Exclusive versus mixed breastfeeding 4-6 months, developing countries, controlled trials, Outcome 18 Plasma ferritin concentration < 12 mcg/L at 6 months. |
| Analysis 1.19. Comparison 1 Exclusive versus mixed breastfeeding 4-6 months, developing countries, controlled trials, Outcome 19 Plasma ferritin concentration < 15 mcg/L at 6 months. |
| Analysis 1.20. Comparison 1 Exclusive versus mixed breastfeeding 4-6 months, developing countries, controlled trials, Outcome 20 Plasma zinc concentration < 70 mcg/dL at 6 months. |
| Analysis 1.21. Comparison 1 Exclusive versus mixed breastfeeding 4-6 months, developing countries, controlled trials, Outcome 21 % of days with fever 4-6 months. |
| Analysis 1.22. Comparison 1 Exclusive versus mixed breastfeeding 4-6 months, developing countries, controlled trials, Outcome 22 % of days with cough 4-6 months. |
| Analysis 1.23. Comparison 1 Exclusive versus mixed breastfeeding 4-6 months, developing countries, controlled trials, Outcome 23 % of days with nasal congestion 4-6 months. |
| Analysis 1.24. Comparison 1 Exclusive versus mixed breastfeeding 4-6 months, developing countries, controlled trials, Outcome 24 % of days with nasal discharge 4-6 months. |
| Analysis 1.25. Comparison 1 Exclusive versus mixed breastfeeding 4-6 months, developing countries, controlled trials, Outcome 25 % of days with hoarseness 4-6 months. |
| Analysis 1.26. Comparison 1 Exclusive versus mixed breastfeeding 4-6 months, developing countries, controlled trials, Outcome 26 % of days with diarrhea 4-6 months. |
| Analysis 1.27. Comparison 1 Exclusive versus mixed breastfeeding 4-6 months, developing countries, controlled trials, Outcome 27 % of days with fever 6-12 months. |
| Analysis 1.28. Comparison 1 Exclusive versus mixed breastfeeding 4-6 months, developing countries, controlled trials, Outcome 28 % of days with nasal congestion 6-12 months. |
| Analysis 1.29. Comparison 1 Exclusive versus mixed breastfeeding 4-6 months, developing countries, controlled trials, Outcome 29 % of days with diarrhea 6-12 months. |
| Analysis 1.30. Comparison 1 Exclusive versus mixed breastfeeding 4-6 months, developing countries, controlled trials, Outcome 30 Age first crawled (mo). |
| Analysis 1.31. Comparison 1 Exclusive versus mixed breastfeeding 4-6 months, developing countries, controlled trials, Outcome 31 Age first sat from lying position (mo). |
| Analysis 1.32. Comparison 1 Exclusive versus mixed breastfeeding 4-6 months, developing countries, controlled trials, Outcome 32 Did not walk by 12 months. |
| Analysis 1.33. Comparison 1 Exclusive versus mixed breastfeeding 4-6 months, developing countries, controlled trials, Outcome 33 Maternal postpartum weight loss 4-6 months (kg). |
| Analysis 1.34. Comparison 1 Exclusive versus mixed breastfeeding 4-6 months, developing countries, controlled trials, Outcome 34 Maternal resumption of menses 6 months postpartum. |
| Analysis 2.1. Comparison 2 Exclusive versus mixed breastfeeding 3-7 months, developing countries, observational studies, Outcome 1 Monthly weight gain 4-6 months (g/mo). |
| Analysis 2.2. Comparison 2 Exclusive versus mixed breastfeeding 3-7 months, developing countries, observational studies, Outcome 2 Monthly weight gain 6-9 months (g/mo). |
| Analysis 2.3. Comparison 2 Exclusive versus mixed breastfeeding 3-7 months, developing countries, observational studies, Outcome 3 Monthly length gain 4-6 months (cm/mo). |
| Analysis 2.4. Comparison 2 Exclusive versus mixed breastfeeding 3-7 months, developing countries, observational studies, Outcome 4 Monthly length gain 6-9 months (cm/mo). |
| Analysis 2.5. Comparison 2 Exclusive versus mixed breastfeeding 3-7 months, developing countries, observational studies, Outcome 5 Weight-for-age z-score at 6-7 months. |
| Analysis 2.6. Comparison 2 Exclusive versus mixed breastfeeding 3-7 months, developing countries, observational studies, Outcome 6 Weight-for-age z-score at 9-10 months. |
| Analysis 2.7. Comparison 2 Exclusive versus mixed breastfeeding 3-7 months, developing countries, observational studies, Outcome 7 Length-for-age z-score at 6-7 months. |
| Analysis 2.8. Comparison 2 Exclusive versus mixed breastfeeding 3-7 months, developing countries, observational studies, Outcome 8 Length-for-age z-score at 9-10 months. |
| Analysis 2.9. Comparison 2 Exclusive versus mixed breastfeeding 3-7 months, developing countries, observational studies, Outcome 9 Weight-for-length z-score at 6-7 months. |
| Analysis 2.10. Comparison 2 Exclusive versus mixed breastfeeding 3-7 months, developing countries, observational studies, Outcome 10 Weight-for-length z-score at 9-10 months. |
| Analysis 2.11. Comparison 2 Exclusive versus mixed breastfeeding 3-7 months, developing countries, observational studies, Outcome 11 Weight-for-age z-score < -2 at 6-7 months. |
| Analysis 2.12. Comparison 2 Exclusive versus mixed breastfeeding 3-7 months, developing countries, observational studies, Outcome 12 Weight-for-age z-score < -2 at 9-10 months. |
| Analysis 2.13. Comparison 2 Exclusive versus mixed breastfeeding 3-7 months, developing countries, observational studies, Outcome 13 Length-for-age z-score < -2 at 6-7 months. |
| Analysis 2.14. Comparison 2 Exclusive versus mixed breastfeeding 3-7 months, developing countries, observational studies, Outcome 14 Length-for-age z-score < -2 at 9-10 months. |
| Analysis 2.15. Comparison 2 Exclusive versus mixed breastfeeding 3-7 months, developing countries, observational studies, Outcome 15 Weight-for-length z-score < -2 at 6-7 months. |
| Analysis 2.16. Comparison 2 Exclusive versus mixed breastfeeding 3-7 months, developing countries, observational studies, Outcome 16 Weight-for-length z-score < -2 at 9-10 months. |
| Analysis 2.17. Comparison 2 Exclusive versus mixed breastfeeding 3-7 months, developing countries, observational studies, Outcome 17 Mid-upper arm circumference at 6-7 months (cm). |
| Analysis 2.18. Comparison 2 Exclusive versus mixed breastfeeding 3-7 months, developing countries, observational studies, Outcome 18 Mid-upper arm circumference at 9-10 months (cm). |
| Analysis 2.19. Comparison 2 Exclusive versus mixed breastfeeding 3-7 months, developing countries, observational studies, Outcome 19 One or more episodes of gastrointestinal infection at 4-6 months. |
| Analysis 2.20. Comparison 2 Exclusive versus mixed breastfeeding 3-7 months, developing countries, observational studies, Outcome 20 One or more episodes of respiratory infection at 4-6 months. |
| Analysis 2.21. Comparison 2 Exclusive versus mixed breastfeeding 3-7 months, developing countries, observational studies, Outcome 21 Resumption of menses by 6-7 months postpartum. |
| Analysis 3.1. Comparison 3 Prolonged (> 6 months) exclusive versus mixed breastfeeding, developing countries, observational studies, Outcome 1 Weight-for-age < 75% of reference mean. |
| Analysis 4.1. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 1 Monthly weight gain 3-8 months (g/mo). |
| Analysis 4.2. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 2 Monthly weight gain 6-9 months (g/mo). |
| Analysis 4.3. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 3 Monthly weight gain 8-12 months (g/mo). |
| Analysis 4.4. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 4 Monthly length gain 3-8 months (cm/mo). |
| Analysis 4.5. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 5 Monthly length gain 6-9 months (cm/mo). |
| Analysis 4.6. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 6 Monthly length gain 8-12 months (cm/mo). |
| Analysis 4.7. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 7 Weight-for-age z-score at 6 months. |
| Analysis 4.8. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 8 Weight-for-age z-score at 9 months. |
| Analysis 4.9. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 9 Weight-for-age z-score at 12 months. |
| Analysis 4.10. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 10 Length-for-age z-score at 6 months. |
| Analysis 4.11. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 11 Length-for-age z-score at 9 months. |
| Analysis 4.12. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 12 Length-for-age z-score at 12 months. |
| Analysis 4.13. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 13 Weight-for-length z-score at 6 months. |
| Analysis 4.14. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 14 Weight-for-length z-score at 9 months. |
| Analysis 4.15. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 15 Weight-for-length z-score at 12 months. |
| Analysis 4.16. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 16 Weight-for-age z-score < -2 at 6 months. |
| Analysis 4.17. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 17 Weight-for-age z-score < -2 at 9 months. |
| Analysis 4.18. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 18 Weight-for-age z-score < -2 at 12 months. |
| Analysis 4.19. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 19 Length-for-age z-score < -2 at 6 months. |
| Analysis 4.20. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 20 Length-for-age z-score < -2 at 9 months. |
| Analysis 4.21. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 21 Length-for-age z-score < -2 at 12 months. |
| Analysis 4.22. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 22 Weight-for-length z-score < -2 at 6 months. |
| Analysis 4.23. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 23 Weight-for-length z-score < -2 at 9 months. |
| Analysis 4.24. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 24 Weight-for-length z-score < -2 at 12 months. |
| Analysis 4.25. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 25 Head circumference at 6 months (cm). |
| Analysis 4.26. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 26 Head circumference at 9 months (cm). |
| Analysis 4.27. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 27 Head circumference at 12 months (cm). |
| Analysis 4.28. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 28 Sleeping time at 9 months (min/day). |
| Analysis 4.29. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 29 Total essential amino acid concentration (umol/L) at 6 months. |
| Analysis 4.30. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 30 Total amino acid concentration (umol/L) at 6 months. |
| Analysis 4.31. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 31 Atopic eczema in first 12 months. |
| Analysis 4.32. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 32 Food allergy at 1 year (by history). |
| Analysis 4.33. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 33 Food allergy at 1 year (by double challenge). |
| Analysis 4.34. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 34 Two or more episodes of wheezing in first 12 months. |
| Analysis 4.35. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 35 Any atopy at 5 years. |
| Analysis 4.36. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 36 Atopic eczema at 5 years. |
| Analysis 4.37. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 37 Pollen allergy at 5 years. |
| Analysis 4.38. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 38 Asthma at 5-6 years. |
| Analysis 4.39. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 39 Food allergy at 5 years (by history). |
| Analysis 4.40. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 40 Allergy to animal dander at 5 years. |
| Analysis 4.41. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 41 Positive skin prick test at 6 years. |
| Analysis 4.42. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 42 Hemoglobin concentration (g/L) at 12 months. |
| Analysis 4.43. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 43 Hemoglobin concentration < 110 g/L at 12 months. |
| Analysis 4.44. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 44 Serum ferritin concentration (mcg/L) at 12 months. |
| Analysis 4.45. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 45 Serum ferritin concetration < 10 mcg/L at 12 months. |
| Analysis 4.46. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 46 Death in first 12 months. |
| Analysis 4.47. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 47 One or more episodes of gastrointestinal infection in first 12 months. |
| Analysis 4.48. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 48 Hospitalization for gastrointestinal infection in first 12 months. |
| Analysis 4.49. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 49 One or more episodes of upper respiratory tract infection in first 12 months. |
| Analysis 4.50. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 50 Two or more episodes of upper respiratory tract infection in first 12 months. |
| Analysis 4.51. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 51 Four or more episodes of upper respiratory tract infection in first 12 months. |
| Analysis 4.52. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 52 One or more episodes of lower respiratory tract infection in first 12 months. |
| Analysis 4.53. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 53 Two or more episodes of respiratory tract infection (upper or lower) in first 12 months. |
| Analysis 4.54. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 54 Hospitalization for respiratory tract infection in first 12 months. |
| Analysis 4.55. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 55 Number of episodes of otitis media in first 12 months. |
| Analysis 4.56. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 56 One or more episodes of otitis media in first 12 months. |
| Analysis 4.57. Comparison 4 Exclusive versus mixed breastfeeding 3-7 months, developed countries, observational studies, Outcome 57 Frequent otitis media in first 12 months. |
| Analysis 5.1. Comparison 5 Exclusive versus mixed breastfeeding > 7 months, developed countries, observational studies, Outcome 1 Very low density lipoprotein concentration (mmol/L) at 9 months. |
| Analysis 5.2. Comparison 5 Exclusive versus mixed breastfeeding > 7 months, developed countries, observational studies, Outcome 2 Low density lipoproteinconcentration (mmol/L) at 9 months. |
| Analysis 5.3. Comparison 5 Exclusive versus mixed breastfeeding > 7 months, developed countries, observational studies, Outcome 3 High-density lipoprotein-2 concentration (mmol/L) at 9 months. |
| Analysis 5.4. Comparison 5 Exclusive versus mixed breastfeeding > 7 months, developed countries, observational studies, Outcome 4 High-density lipoprotein-3 concentration (mmol/L) at 9 months. |
| Analysis 5.5. Comparison 5 Exclusive versus mixed breastfeeding > 7 months, developed countries, observational studies, Outcome 5 Apoprotein B concentration (mg/dL) at 9 months. |
| Analysis 5.6. Comparison 5 Exclusive versus mixed breastfeeding > 7 months, developed countries, observational studies, Outcome 6 Total triglyceride concentration (mmol/L) at 9 months. |
![[Analysis 1.1]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-001-01.png?v=1&t=h2r4mrzw&s=cf42a1b84f711ca7bcecbe0a3b9305135c034ef8)
![[Analysis 1.2]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-001-02.png?v=1&t=h2r4mrzz&s=f59201d888b0207bf54804ef3d5082c817af78fe)
![[Analysis 1.3]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-001-03.png?v=1&t=h2r4ms02&s=f268b4dca1417b383267979e5044211bfe9e1b79)
![[Analysis 1.4]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-001-04.png?v=1&t=h2r4ms05&s=f707a134db03a6af1ca7ea1d4444bf3db51dd4a7)
![[Analysis 1.5]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-001-05.png?v=1&t=h2r4ms08&s=6bb2bcbe7112e20b119fc72f153104f5223a8d9e)
![[Analysis 1.6]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-001-06.png?v=1&t=h2r4ms0b&s=913c544c9f34a2f886b0dda5e62c34648c3b0ab4)
![[Analysis 1.7]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-001-07.png?v=1&t=h2r4ms0e&s=2786c998b016894b55f5265ba6ce5b325e96fe95)
![[Analysis 1.8]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-001-08.png?v=1&t=h2r4ms0h&s=51e097c6004494e632ce7fcc864f69fff9c6e07b)
![[Analysis 1.9]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-001-09.png?v=1&t=h2r4ms0k&s=27e2b5f5a8e2042e0df730e6202488b210aeb6ac)
![[Analysis 1.10]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-001-10.png?v=1&t=h2r4ms0m&s=b9f2f8a0ff7506325bbfda3df5bf312ad1805269)
![[Analysis 1.11]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-001-11.png?v=1&t=h2r4ms0p&s=1e39f75af684ace1736830a58640cedb287669b9)
![[Analysis 1.12]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-001-12.png?v=1&t=h2r4ms0r&s=4c29b7226fbfcbe413332b6b88dc4434725870a8)
![[Analysis 1.13]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-001-13.png?v=1&t=h2r4ms0t&s=b36a68778574e9e96a562d1353bf13faf3ea9715)
![[Analysis 1.14]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-001-14.png?v=1&t=h2r4ms0w&s=520c50eebe22a4bbe8c0e7c1e24e880a9f7824ff)
![[Analysis 1.15]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-001-15.png?v=1&t=h2r4ms0y&s=cff50fd5aafba5861213be467ec737743462efd1)
![[Analysis 1.16]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-001-16.png?v=1&t=h2r4ms11&s=e6ee2f9587fcb2e3743253f7cb1a9e59c2c907be)
![[Analysis 1.17]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-001-17.png?v=1&t=h2r4ms14&s=053b8b4e5cd6bf93364d112eab4aeca8f122e39e)
![[Analysis 1.18]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-001-18.png?v=1&t=h2r4ms17&s=a3a3909a8681a95ff7e239b694b3306ef8f3e9d6)
![[Analysis 1.19]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-001-19.png?v=1&t=h2r4ms1a&s=407c2c6ce41ce34036b496354396e4f1cddab73d)
![[Analysis 1.20]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-001-20.png?v=1&t=h2r4ms1d&s=4a5a8ec6c2cbe96089b7c31b3c43c1f09bc9a1ce)
![[Analysis 1.21]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-001-21.png?v=1&t=h2r4ms1f&s=3f0f79c53bceb721a6097943b81cf3866c0d3ebd)
![[Analysis 1.22]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-001-22.png?v=1&t=h2r4ms1i&s=6f363e84baca1755d3943450dcbbd681d8eb6cfe)
![[Analysis 1.23]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-001-23.png?v=1&t=h2r4ms1k&s=a767e8ac97365e0253a8dbf1140c60ae4e7779d4)
![[Analysis 1.24]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-001-24.png?v=1&t=h2r4ms1o&s=21be37645f8892e0c1424ba855d186dd34b4d541)
![[Analysis 1.25]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-001-25.png?v=1&t=h2r4ms1r&s=2dc5a303a349fdf3ec3afcfde63e0d354dba1e56)
![[Analysis 1.26]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-001-26.png?v=1&t=h2r4ms1u&s=230936da4a0bf230c644d2813303e90bd8f82c8c)
![[Analysis 1.27]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-001-27.png?v=1&t=h2r4ms1x&s=a881ab0629e7e068d20ee1878610cfd2bb1575a8)
![[Analysis 1.28]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-001-28.png?v=1&t=h2r4ms1z&s=542aec0b63f8746e9ebc8a105efd378fcd3d9072)
![[Analysis 1.29]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-001-29.png?v=1&t=h2r4ms22&s=2d7e908ce714749a1cf40edc0f654b9b0b8fc0d1)
![[Analysis 1.30]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-001-30.png?v=1&t=h2r4ms24&s=2e94144157d05029f37b07a43bc1aadd6a9ceb77)
![[Analysis 1.31]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-001-31.png?v=1&t=h2r4ms26&s=7c00db05e31e94144ba09b96a8a5e222196760a8)
![[Analysis 1.32]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-001-32.png?v=1&t=h2r4ms29&s=aaede5051baf04457964ca220491ac412bda7ede)
![[Analysis 1.33]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-001-33.png?v=1&t=h2r4ms2c&s=18ffb71c535d69b37138d16e9575eadd28b42223)
![[Analysis 1.34]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-001-34.png?v=1&t=h2r4ms2e&s=43f4428d0b2752dfc577abf168307518d0485565)
![[Analysis 2.1]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-002-01.png?v=1&t=h2r4ms2h&s=0465e973a977bec7ada47de01afd20c5f2b203ce)
![[Analysis 2.2]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-002-02.png?v=1&t=h2r4ms2j&s=9b045e56120207f0b2353afa63460352f4acc34f)
![[Analysis 2.3]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-002-03.png?v=1&t=h2r4ms2m&s=6655f8e5b4bfdd80c9439748d495e8309740a65b)
![[Analysis 2.4]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-002-04.png?v=1&t=h2r4ms2o&s=2bcd6f3360b2fe902f2b9b1353cbfd5b1d02ef40)
![[Analysis 2.5]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-002-05.png?v=1&t=h2r4ms2r&s=9c3879c6f47dfa9736d2634c7620494959588658)
![[Analysis 2.6]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-002-06.png?v=1&t=h2r4ms2t&s=c35157bf304dfca78571b6b56147fa5bd107c65f)
![[Analysis 2.7]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-002-07.png?v=1&t=h2r4ms2w&s=664d2687732d4d5b64e27a34f7a99f1d5a68816d)
![[Analysis 2.8]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-002-08.png?v=1&t=h2r4ms2y&s=062f2b8450b32024782e5c43d7e8bfd7bc38831e)
![[Analysis 2.9]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-002-09.png?v=1&t=h2r4ms30&s=49bda6852b6c24619d0adbdf9f4c196a3237e866)
![[Analysis 2.10]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-002-10.png?v=1&t=h2r4ms33&s=7d8b0cc30fe7af30569ab33188d166d8a1d060a3)
![[Analysis 2.11]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-002-11.png?v=1&t=h2r4ms36&s=1a545f4327b98deec32e1fbf3f01b621616da62d)
![[Analysis 2.12]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-002-12.png?v=1&t=h2r4ms38&s=085591ac2ed92863831cf074a6cc5d96993aa7a9)
![[Analysis 2.13]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-002-13.png?v=1&t=h2r4ms3b&s=29cee9737169f8f528714d17a13013629813c2e2)
![[Analysis 2.14]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-002-14.png?v=1&t=h2r4ms3d&s=20aec69db30f42400d5be473e59eddf0ad03c47b)
![[Analysis 2.15]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-002-15.png?v=1&t=h2r4ms3g&s=f4270ef23b196b3eb21e829dc07c9c7abb1229ea)
![[Analysis 2.16]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-002-16.png?v=1&t=h2r4ms3j&s=6bd1e1d61576553ce9a4c2e575c70f2ca558fa9d)
![[Analysis 2.17]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-002-17.png?v=1&t=h2r4ms3l&s=073e3730ba5555887fcab339756256e3774b3545)
![[Analysis 2.18]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-002-18.png?v=1&t=h2r4ms3o&s=8952437f75843d89f9ccc60127c035aacbefef3a)
![[Analysis 2.19]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-002-19.png?v=1&t=h2r4ms3q&s=d4d9a870a5cf15a468989b2bc0be0f17230dadf0)
![[Analysis 2.20]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-002-20.png?v=1&t=h2r4ms3t&s=c7615a26d84e5e3dd71515c08cf5a21f717e31fd)
![[Analysis 2.21]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-002-21.png?v=1&t=h2r4ms3w&s=73aba3d51f6145de0c880fb3c5230b45a969ba82)
![[Analysis 3.1]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-003-01.png?v=1&t=h2r4ms3z&s=44dcf0cfd3b0397f4739d4ae3b1fc9ce0adb1acc)
![[Analysis 4.1]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-01.png?v=1&t=h2r4ms42&s=48a74ecb57be0522bcd9046c42878d8efdf6a5b0)
![[Analysis 4.2]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-02.png?v=1&t=h2r4ms45&s=f51296d95112f93f0ccd6dab2406363f885ae367)
![[Analysis 4.3]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-03.png?v=1&t=h2r4ms47&s=fb82cc67d40af9f5a409dbcae36e132b17427a1e)
![[Analysis 4.4]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-04.png?v=1&t=h2r4ms4a&s=ea1af4e9293efda7f245a3d43182d1d52ac5b7c6)
![[Analysis 4.5]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-05.png?v=1&t=h2r4ms4c&s=8e1a181869a7736969770d726abe6ff09af526d3)
![[Analysis 4.6]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-06.png?v=1&t=h2r4ms4f&s=acbbd8071983aa53c2a9ae37c0ad9ab92b8baf69)
![[Analysis 4.7]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-07.png?v=1&t=h2r4ms4h&s=520e8b0d4342a862effc0cd3d2293d74ca84dd7c)
![[Analysis 4.8]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-08.png?v=1&t=h2r4ms4k&s=7d640730e8aa677e5c16a2d322610d3bbe45a2a6)
![[Analysis 4.9]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-09.png?v=1&t=h2r4ms4m&s=b54e9539808189210c3ddc3a680c11bc672e6674)
![[Analysis 4.10]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-10.png?v=1&t=h2r4ms4p&s=bd1e8b6e231fa89ac2ba6bcd9ef4fa70889106f9)
![[Analysis 4.11]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-11.png?v=1&t=h2r4ms4r&s=a47f830c0e7132dfb7410e1a3406a26847244174)
![[Analysis 4.12]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-12.png?v=1&t=h2r4ms4u&s=60791041be0a26e9bf72b1e711f297edbfbffd52)
![[Analysis 4.13]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-13.png?v=1&t=h2r4ms4w&s=9a35bb631714e7d876e57107cc52b2dbee86e071)
![[Analysis 4.14]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-14.png?v=1&t=h2r4ms4z&s=ea3d35f2c26ff99aec28fad3d72136f5c6ed1315)
![[Analysis 4.15]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-15.png?v=1&t=h2r4ms51&s=2a6d3e84d329f06a6dacaa63d3070b0eaf48e881)
![[Analysis 4.16]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-16.png?v=1&t=h2r4ms54&s=b4e300ce6f63d2113b6878732c86aeeed5b650e3)
![[Analysis 4.17]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-17.png?v=1&t=h2r4ms56&s=07c780f057f69a92cd4112bc9e5103bf53172584)
![[Analysis 4.18]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-18.png?v=1&t=h2r4ms59&s=ad24c8c0bee3eb61492c00dc585e462a4bcf9683)
![[Analysis 4.19]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-19.png?v=1&t=h2r4ms5b&s=a69d621f9b425d79b140aee0f08862653fecbfd6)
![[Analysis 4.20]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-20.png?v=1&t=h2r4ms5e&s=f58bc9399a41bb4aa11c32e4548e1b773d7a1418)
![[Analysis 4.21]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-21.png?v=1&t=h2r4ms5g&s=ebed15a0005a1239a2ed9de531d93ee15f935947)
![[Analysis 4.22]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-22.png?v=1&t=h2r4ms5j&s=13f3fc237f2ef2f336b8d9b09eda407f8c961d9f)
![[Analysis 4.23]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-23.png?v=1&t=h2r4ms5l&s=83c6bb2b2e1d709e558be276dfd61bdf144faa64)
![[Analysis 4.24]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-24.png?v=1&t=h2r4ms5o&s=bac4f6f7b023844904678754d223f68e67f47311)
![[Analysis 4.25]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-25.png?v=1&t=h2r4ms5r&s=037681932462eb570860bd9c212c96ebe2556f3d)
![[Analysis 4.26]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-26.png?v=1&t=h2r4ms5t&s=eb8fd7035f5cd9b9156dae00a7b61960911244d3)
![[Analysis 4.27]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-27.png?v=1&t=h2r4ms5w&s=e14642b36b6008d24fb874900f2720483b711064)
![[Analysis 4.28]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-28.png?v=1&t=h2r4ms60&s=394b21b4ae18f43504277e723bc7a6c580e9b555)
![[Analysis 4.29]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-29.png?v=1&t=h2r4ms63&s=e555eccc641e7211d24d3199f90081dbe6535e06)
![[Analysis 4.30]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-30.png?v=1&t=h2r4ms65&s=9206ca414b2847d4470b0cab7fa71338c8bfb8fd)
![[Analysis 4.31]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-31.png?v=1&t=h2r4ms68&s=e4942ca63dbfbd54f6a35e5a43e99bde5ff7c998)
![[Analysis 4.32]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-32.png?v=1&t=h2r4ms6b&s=7393c268621c5011dca03c090961ceef0933a2dc)
![[Analysis 4.33]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-33.png?v=1&t=h2r4ms6d&s=e7ef81cec85246f73664d0d0d2dc4ce937a15cf0)
![[Analysis 4.34]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-34.png?v=1&t=h2r4ms6g&s=b097433397490a5793a931a42010cc9aee3accbd)
![[Analysis 4.35]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-35.png?v=1&t=h2r4ms6i&s=cc62de3ae9be6868609cc24baa14569d23671eaf)
![[Analysis 4.36]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-36.png?v=1&t=h2r4ms6l&s=54d2612d561cabee12f232ff995df60bdf08207c)
![[Analysis 4.37]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-37.png?v=1&t=h2r4ms6o&s=48e8c4eda4632fb1d3b70d52ca89225271459dcf)
![[Analysis 4.38]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-38.png?v=1&t=h2r4ms6q&s=bd6c5ca733bee6d0f868dc1ed5769d9144de9a00)
![[Analysis 4.39]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-39.png?v=1&t=h2r4ms6t&s=595de6e942f42062ff01007805516af76488a6ea)
![[Analysis 4.40]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-40.png?v=1&t=h2r4ms6v&s=85c793f098541aca3d5d059eabce65dda2ce0b1d)
![[Analysis 4.41]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-41.png?v=1&t=h2r4ms6y&s=b833429b29ec89ccadbc93780bde65d04e76bb59)
![[Analysis 4.42]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-42.png?v=1&t=h2r4ms71&s=4e99976e21ee42bdfd409337342fb5f0fc71bfca)
![[Analysis 4.43]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-43.png?v=1&t=h2r4ms74&s=d0db5151d70261f3550380d102e18736712cbb27)
![[Analysis 4.44]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-44.png?v=1&t=h2r4ms77&s=cb908ed9c498e0166756161e44e25801b0fb77ff)
![[Analysis 4.45]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-45.png?v=1&t=h2r4ms7a&s=464c14f7e1d9542071bbe46b9012fdf77453c034)
![[Analysis 4.46]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-46.png?v=1&t=h2r4ms7c&s=faebaa8871782e65d47e7693e6c4018c72bda610)
![[Analysis 4.47]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-47.png?v=1&t=h2r4ms7f&s=0e4ca07dd2279d1780adc760c7d947a4f30e9421)
![[Analysis 4.48]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-48.png?v=1&t=h2r4ms7i&s=ab3306b861921b2f3d4041379146efa4eb45926f)
![[Analysis 4.49]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-49.png?v=1&t=h2r4ms7l&s=94030778c0e912cbfebb4025654e786678be62bd)
![[Analysis 4.50]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-50.png?v=1&t=h2r4ms7o&s=4eb8855341085d34665a58620910562d9bf4cae3)
![[Analysis 4.51]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-51.png?v=1&t=h2r4ms7r&s=538df386879e24ce3ebc0965b1ce58d2bdc90907)
![[Analysis 4.52]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-52.png?v=1&t=h2r4ms7u&s=bb7055374326cfa934f11e43c4da388eb64a634e)
![[Analysis 4.53]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-53.png?v=1&t=h2r4ms7y&s=5cab55b485ad55acdb78e1c5087851adaf6095e2)
![[Analysis 4.54]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-54.png?v=1&t=h2r4ms81&s=8453886bba3b204a69f7b5404fd0d35d3d4048b8)
![[Analysis 4.55]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-55.png?v=1&t=h2r4ms85&s=03069a22075d924816b33290edd276f264fd830a)
![[Analysis 4.56]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-56.png?v=1&t=h2r4ms88&s=f470e6901968c242f453ba63ce2580f0f34eff8c)
![[Analysis 4.57]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-004-57.png?v=1&t=h2r4ms8c&s=8d0f556906f12de6fb513a3d120ec686f27edbcc)
![[Analysis 5.1]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-005-01.png?v=1&t=h2r4ms8f&s=2c638f229570de3154bd90fd794eb751b60e1288)
![[Analysis 5.2]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-005-02.png?v=1&t=h2r4ms8i&s=9e0d8f06415ba2033729daf87f4a76d550d61c03)
![[Analysis 5.3]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-005-03.png?v=1&t=h2r4ms8m&s=a6c16f0f786adceceb6b3912537dc72774bbdc19)
![[Analysis 5.4]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-005-04.png?v=1&t=h2r4ms8p&s=f0aebdb743fe43fc3ad2f1fd0f03c78b853d699b)
![[Analysis 5.5]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-005-05.png?v=1&t=h2r4ms8s&s=13fd32cc6eafc5b824c278c8bdf6f41b90e3c132)
![[Analysis 5.6]](http://onlinelibrary.wiley.com/store/mrw_content/cochrane/clsysrev/articles/CD003517/image_n/nCD003517-CMP-005-06.png?v=1&t=h2r4ms8w&s=99a99a8bdddadebc2844bc732fe73977c66d5598)